Healthnomic wants to debut on NewConnect in the coming year, said ISBtech CEO Paweł Wiśniewski. It wants to close the documentation related to the process in the first quarter of 2023. “We are aiming for 2023. We want to close all documentation related to the process in the first quarter of next year. Undoubtedly, the stock exchange debut will be a big step in our development. It will allow our projects to be exposed to investors from Poland and abroad, but will also increase the reputation and prestige during talks about the commercialization and sale of the solutions we are already running,” said ISBtech Wiśniewski. He added that although the current market is not ideal for companies looking to raise capital, he believes that "there will always be funds for valuable projects". Before going public, the company is considering raising capital. The company is developing the project of the OmniHealth telemedicine platform, a research management system. Together with the platform, Healthnomic develops medical devices that will help detect new civilization diseases. The recorder currently used by the company examines sleep apnea, but the company is also developing another device, Apnomic GX3, which will support the diagnosis of other civilization diseases. Healthnomic S.A. is a technology hub for the diagnosis of lifestyle diseases, based on proprietary solutions, supported by automatic algorithms. The company also develops therapeutic solutions for selected diseases. The company develops the technology to the stage of commercialization, and then sells or licenses it. Source
23.12.2022